ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
Alessandra Gennari(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Fabrice André(Institut Gustave Roussy), Carlos H. Barrios(Grupo Hospitalar Conceição), Javier Cortés(Universidad Europea), Evandro de Azambuja(Université Libre de Bruxelles), A. DeMichele(Hospital of the University of Pennsylvania), Rebecca Dent(National Cancer Centre Singapore), Deborah Fenlon(Swansea University), Joseph Gligorov(Assistance Publique – Hôpitaux de Paris), Sara A. Hurvitz(University of California, Los Angeles), Seock‐Ah Im(Seoul National University Hospital), David Krug(University Hospital Schleswig-Holstein), Wolfgang G. Kunz(LMU Klinikum), Sherene Loi(Peter MacCallum Cancer Centre), Frédérique Penault‐Llorca(Université Clermont Auvergne), Jens Ricke(Ludwig-Maximilians-Universität München), Mark E. Robson(Memorial Sloan Kettering Cancer Center), Hope S. Rugo(University of California, San Francisco), Cristina Saura(Vall d'Hebron Institute of Oncology), Peter Schmid(Cancer Research UK), Christian F. Singer(Medical University of Vienna), Tanja Španič(Alma Mater Europaea), Sara M. Tolaney(Dana-Farber Cancer Institute), Nicholas C. Turner(Royal Marsden Hospital), Giuseppe Curigliano(University of Milan), Sibylle Loibl(German Breast group), Shani Paluch–Shimon(Hebrew University of Jerusalem), Nadia Harbeck(Ludwig-Maximilians-Universität München)
Cited by 1,340Open Access